2022 European Society for Medical Oncology Congress Coverage

The European Society for Medical Oncology Congress brings together clinicians, researchers, and advocates to discuss the latest cancer study results. We're proud to present our coverage below.

Verzenio Plus Aromatase Inhibitor Improves Survival in Advanced-Stage, Hormone Receptor-Positive, HER2-Negative Breast Cancer

Hand Cooling, Compression Nearly Halve Risk of Neuropathy From Chemotherapy

Trodelvy Slightly Improves Overall Survival for Heavily Pre-treated Metastatic, Hormone Receptor-Positive, HER2-Negative Breast Cancer

People With Metastatic HER2-Low Breast Cancer Report How Enhertu Affected Their Quality of Life

New CDK4/6 Inhibitor Offers Benefits for Advanced-Stage, Hormone Receptor-Positive, HER2-Negative Breast Cancer

Verzenio Improves Overall Survival in Hormone Receptor-Positive, HER2-Negative, Advanced Stage Breast Cancer

Trodelvy Offers Benefits for Hormone Receptor-Positive Breast Cancer

Enhertu for HER2-Low Breast Cancer: Patient-Reported Outcomes